You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -27.3% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -225.6 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 61.9 | 0.0 |
| Price / Book value | 0.9 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | n/a | n/a |
| EPS | n/a | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | 14.56 | 5.92 | 1.28p | 113.3 | -6.9 | -16% | 2.30p | 1.6% |
| 2018-03-31 | 28.75 | 5.14 | 0.78p | 239.2 | -6.1 | -39% | 2.30p | 1.2% |
| 2019-03-31 | 34.63 | 6.78 | 1.03p | 251.5 | 7.8 | 32% | n/a | 0.0% |
| 2020-03-31 | 35.71 | 7.46 | 1.13p | 184.1 | 19.0 | 10% | n/a | 0.0% |
| 2021-03-31 | 19.93 | -5.45 | -0.82p | -309.8 | 0.0 | n/a | n/a | 0.0% |
| Syncona sells Gyroscope to Novartis for up to $1.5bn Sharecast News | 22 Dec |
|---|---|
| Syncona net asset value slips in first half Sharecast News | 11 Nov |
| Syncona's Freeline makes progress in dose-finding trials Sharecast News | 10 Nov |
| Directorate Change | 31-Dec-21 07:00 |
|---|---|
| Gyroscope to be acquired for up to $1.5 billion | 22-Dec-21 07:00 |
| Syncona cornerstones Anaveon Series B | 16-Dec-21 07:00 |
| Freeline reports 2022 priorities and guidance | 14-Dec-21 07:00 |
| Freeline presents data in haemophilia B | 13-Dec-21 14:05 |